MedaSystems for
Post-Trial Access
Continue treating patients after clinical trials end
Collaborate with healthcare providers to transition trial participants to Expanded Access/Compassionate Use, in order to minimize gaps in a patient’s treatment.
Utilize MedaSystems’ software to capture incoming healthcare provider requests for Post-Trial Access, from patient enrollment through to resupply of treatment.
Ensure patients have a seamless transition from clinical trials to Post-Trial Access
Easy enrollment
Quickly enroll patients who have benefited from treatment during clinical trials into a PTA offering that allows continuity of treatment.
Cost effective
By leveraging Expanded Access for Post-Trial Access, sponsors can facilitate continued treatment without needing to operationalize an Open-Label Extension study.
How our customers use MedaSystems for Post-Trial Access
-
Site collaboration
As the clinical trial ends, sponsors invite site physicians and staff into MedaSystems to complete forms and upload necessary documents.
-
Eligibility review
With MedaSystems running in the cloud, multiple colleagues can collaborate in the system simultaneously to make better and faster decisions.
-
Drug shipment
Biopharma teams (and optionally also healthcare providers) can initiate shipments within MedaSystems and also track delivery.
-
Treatment history
Use digital forms to capture structured data for reporting, regulatory purposes, internal audits, and shipping.
-
Data analysis
Capture and leverage insights from data in the system to help understand the larger “so what?” that can help drive the business’s goals.
